The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PRE-ISPY phase I/Ib oncology platform program (PRE-I-SPY-P1).
 
Paula R Pohlmann
Leadership - Immunonet BioSciences
Stock and Other Ownership Interests - Immunonet BioSciences
Honoraria - Dava Oncology; Frontiers Media; OncLive/MJH Life Sciences; SABCS
Consulting or Advisory Role - Abbvie; Bolt Biotherapeutics; Caris Life Sciences; HERON; Immunonet BioSciences; Juniper Pharmaceuticals; OncoPlex Diagnostics; Personalized Cancer Therapy; Pfizer; Pfizer; Puma Biotechnology; Sirtex Medical
Speakers' Bureau - Genentech/Roche
Research Funding - Advanced Cancer Therapeutics (Inst); Bolt Biotherapeutics (Inst); Byondis (Inst); Caris Centers of Excellence (Inst); Caris Centers of Excellence (Inst); Carisma Therapeutics (Inst); Cascadian Therapeutics (Inst); Fabre-Kramer (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Orum Therapeutics (Inst); Pfizer (Inst); Pfizer (Inst); Pieris Pharmaceuticals (Inst); SEAGEN (Inst); SEAGEN (Inst); SEAGEN (Inst)
Patents, Royalties, Other Intellectual Property - Patent application; United States Patent no. 8,486,413.; United States Patent no. 8,501,417; United States Patent no. 9,023,362; United States Patent no. 9,745,377
(OPTIONAL) Uncompensated Relationships - Jazz Pharmaceuticals; Pfizer; SEAGEN
 
David Alexander Potter
Honoraria - Dava Oncology; Immunomedics/Gilead; OncLive Clinical Congress Consultants; Puma Biotechnology
Research Funding - Abbvie (Inst); Abbvie (Inst); ImmunoMet (Inst); Innocrin Pharma (Inst); Pfizer (Inst); Takeda Science Foundation (Inst)
Travel, Accommodations, Expenses - Immunomedics/Gilead
 
Nan Chen
Employment - GlaxoSmithKline (I)
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Gilead Sciences; Guardant Health; Seagen; Stemline Therapeutics
 
Jason A Mouabbi
Employment - MD Anderson Cancer Center
Honoraria - BostonGene
Consulting or Advisory Role - AstraZeneca; GE Healthcare; Gilead Sciences; Novartis
Research Funding - Bristol Myers Squibb Foundation (Inst)
(OPTIONAL) Uncompensated Relationships - Lobular Breast Cancer Alliance
 
Murtuza Rampurwala
No Relationships to Disclose
 
Shayan Rayani
No Relationships to Disclose
 
Antoinette R. Tan
Consulting or Advisory Role - AstraZeneca; Jazz Pharmaceuticals; Lilly; OncoLens; Stemline Therapeutics
Research Funding - Arvinas (Inst); G1 Therapeutics (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Incyclix Bio (Inst); Merck (Inst); Olema Pharmaceuticals (Inst); Pfizer (Inst)
 
Roberto Antonio Leon-Ferre
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lyell Immunopharma (Inst)
 
Karthik Giridhar
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Exact Sciences (Inst); Gilead Sciences (Inst); Lilly (Inst); MJH Live Events (Inst); MJH Live Events (Inst); NeoGenomics Laboratories (Inst); Puma Biotechnology (Inst); Tersera (Inst)
Research Funding - Guardant Health (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GRAIL; QuantumLeap Health
 
Judy Caroline Boughey
Honoraria - PeerView; PER; UpToDate
Consulting or Advisory Role - CairnSurgical; SymBioSis (Inst)
Research Funding - Lilly (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending - METHODS AND MATERIALS FOR ASSESSING CHEMOTHERAPY RESPONSIVENESS AND TREATING CANCER (Inst)
Travel, Accommodations, Expenses - Endomagnetics; Endomagnetics
 
Hyo S. Han
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Immunomedics; Novartis
Research Funding - Abbvie (Inst); Arvinas (Inst); Celcuity (Inst); Department of Defense (Inst); G1 Therapeutics (Inst); GlaxoSmithKline (Inst); Marker Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Phoenix Pharmaceuticals (Inst); Pionyr (Inst); QuantumLeap Health (Inst); Seagen (Inst); Senhwa Biosciences (Inst); Zymeworks (Inst)
 
Laura Carpin Kennedy
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Research Funding - Puma Biotechnology (Inst); Roche/Genentech (Inst)
 
Elaine M. Walsh
Consulting or Advisory Role - DeciBio; Seagen
 
Debashish Tripathy
Consulting or Advisory Role - Ambrx; AstraZeneca; Genomic Health; Gilead Sciences; GlaxoSmithKline; Menarini; Novartis; OncoPep; Personalis; Pfizer; Roche; Sermonix Pharmaceuticals
Research Funding - Ambrx (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis
 
Shabnam Jafari
Employment - Quantum Leap Healthcare Collaborative
 
Martin Eklund
Stock and Other Ownership Interests - A3P Biomedical; Clinsight
Consulting or Advisory Role - QuantumLeap Health
Patents, Royalties, Other Intellectual Property - I am an inventor of five pending patent applications related to prostate cancer diagnostics. I do not receive any royalties.
 
Rita Nanda
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Exact Sciences; GE Healthcare; Gilead Sciences; Guardant Health; Merck; Moderna Therapeutics; Novartis; Sanofi; Seagen; Stemline Therapeutics
Research Funding - Arvinas (Inst); AstraZeneca (Inst); Celgene (Inst); Corcept Therapeutics (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Merck (Inst); OBI Pharma (Inst); Odonate Therapeutics (Inst); OncoSec (Inst); Pfizer (Inst); Relay Therapeutics (Inst); Seagen (Inst); Sun Pharma (Inst); Taiho Oncology (Inst)
Other Relationship - G1 Therapeutics
 
Funda Meric-Bernstam
Employment - MD Anderson Cancer Center
Honoraria - Dava Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Black Diamond Therapeutics; Calibr; Daiichi Sankyo/Astra Zeneca; EcoR1 Capital; Eisai; Exelixis; GT Aperion; Incyte; Infinity Pharmaceuticals; Karyopharm Therapeutics; LegoChem Biosciences; Lengo Therapeutics; Menarini Group; OnCusp Therapeutics; Protai; Seagen; Tallac Therapeutics; Theratechnologies; Zentalis; Zymeworks
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Jazz Pharmaceuticals (Inst); Klus Pharma (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - ARTIDIS; Cholangiocarcinoma Foundation; Dava Oncology; ESMO; European Organisation for Research and Treatment of Cancer (EORTC)
 
Douglas Yee
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Martell diagnostic
Research Funding - Boehringer Ingelheim
 
Laura Esserman
Consulting or Advisory Role - Blue Cross Blue Shield Association
Research Funding - Moderna Therapeutics (Inst)
Travel, Accommodations, Expenses - Blue Cross Blue Shield Association
(OPTIONAL) Uncompensated Relationships - Quantum Leap Healthcare Collaborative